Related Experiment Video
Updated: Jun 18, 2026
10:38
Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture
Published on: November 22, 2019
Neuroendocrine differentiation in prostate cancer
American Journal of Translational Research
|December 4, 2009
Summary
Neuroendocrine cells in prostate cancer are androgen-independent and may drive tumor recurrence after hormonal therapy. Understanding their role is crucial for developing effective prostate cancer treatments.
Area of Science:
- Urology
- Oncology
- Cell Biology
Background:
- The human prostate comprises diverse cells, including neuroendocrine cells crucial for gland function.
- Neuroendocrine cells increase in high-grade, high-stage prostate cancer, especially after hormonal treatment.
Purpose of the Study:
- To review the functions of neuroendocrine cells in prostate cancer.
- To explore molecular pathways involved in neuroendocrine differentiation.
Main Methods:
- Literature review of studies on prostate neuroendocrine cells.
- Analysis of the role of neuroendocrine cells in prostate cancer progression and treatment resistance.
Main Results:
- Neuroendocrine cells promote cancer proliferation, invasion, apoptosis resistance, and angiogenesis.
- These cells are likely androgen-independent and may enrich during hormonal therapy.
Conclusions:
- Androgen deprivation therapy may not eliminate neuroendocrine prostate cancer cells.
- Enriched neuroendocrine cells could stimulate androgen-independent tumor growth, leading to recurrence.
